Isabel Healthcare's mission is to improve the speed and appropriateness of patient care across the world by providing clinicians with practical diagnosis decision support solutions.
Isabel Healthcare is a fast growing, venture capital backed company operating on a global basis. The company is best known for Isabel, a web-based, Diagnosis Checklist System designed to assist clinicians that may have diagnostic doubt or want reassurance on a particular diagnosis. Isabel provides a practical and dynamic diagnosis checklist within the normal workflow either as a standalone tool or fully integrated with the Electronic Medical Record (EMR). Isabel enhances the diagnostic determination process by complimenting the expertise of the clinician, minimizing risk at the most important decision point in the care process.
The evidence shows that the most effective way for clinicians to improve the quality and speed of diagnosis is for them to work up a comprehensive hypothesis or list of likely diagnoses for their patient. The Isabel tool enables them to do this within their work flow or even during the patient consultation.
Studies have proven that clinicians who 'Isabel' their patients at an early stage are able to substantially reduce clinical risk by ensuring that important possible diagnoses have not been missed.
Jason and Charlotte Maude co-founded Isabel Healthcare in July 1999 after their then 3 year old daughter Isabel was nearly fatally misdiagnosed by her local hospital. Isabel spent two months in hospital, including a month in PICU after experiencing multiple organ failure and cardiac arrest.
Isabel’s extensive suffering could have been avoided if the local emergency department and family physicians, instead of assuming her symptoms were typical of the chicken pox from which she was also suffering, had stopped to ask 'what else could this be?' Isabel was later diagnosed to be suffering from well-described complications of chicken pox: Toxic Shock Syndrome and Necrotising Fasciitis.
Rather than suing the hospital for the error Isabel Healthcare was created, in honor of Isabel Maude and all patients whose lives have been impacted by missed or delayed diagnosis, to help clinicians around the world do the best job for their patients.
Jason Maude
Chief Executive Officer and Co-founder
Jason Maude serves as Chief Executive Officer and Co-founder of Isabel Healthcare Ltd. Prior to co-founding Isabel Healthcare Ltd, Maude spent 12 years working in the finance and investment banking industry in Europe. Throughout his career, Maude served as a top-ranked equity analyst at Kleinwort Benson Securities, Smith Barney and Dillon Read. While at Dillon Read, a prestigious U.S. investment bank, Maude served as partner and managing director of the company's UK office. This prominent position led Maude to AXA Investment Managers where he led equity research and managed $500 billion global investment initiatives.
In 1999, Maude's three-year-old daughter, Isabel fell seriously ill as a result of a misdiagnosis. Isabel's illness and experience inspired Maude to abandon his city career and create Isabel Healthcare.
Donald H. Bauman, Jr.
Chief Executive Officer, Isabel Healthcare USA
Mr. Bauman joined Isabel in April 2010 and brought with him more than 20 years of experience in healthcare software sales and marketing activities. In his recent tenure in healthcare safety solutions, Mr. Bauman has served as vice president of sales and marketing for InformMed, a provider of innovative medication safety solutions, LMS Medical, a leading provider of obstetrical decision support solutions, and Cereplex Inc., an early stage market innovator in automated infection prevention solutions. His experience includes direct sales, numerous area and national sales leadership roles, product marketing and partnership development at Premier, Inc., Bridge Medical, McKesson, CliniCom and Community Health Computing. Mr. Bauman holds a Bachelor of Science degree from the University of Michigan.
P. Ramnarayan, MRCPCH, MD
Chief Medical Advisor
Dr. Ramnarayan joined Isabel Healthcare in 2000 after establishing the well-known Ram's Teaching Website, now at Medic Central. At Isabel, he led the extensive and ground-breaking validation process to ensure Isabel's accuracy and ongoing capabilities.
Ramnarayan earned his MD from Imperial College and is currently also an Attending Physician at Great Ormond Street Hospital for Children and St. Mary's Hospital in London, UK.
Amanda Tomlinson
Quality Assurance Director
Amanda Tomlinson has been with Isabel Healthcare since 2000. Prior to this, she worked as a senior staff nurse on the Pediatric Infectious Disease ward at one of London's top hospitals, St Mary’s in Paddington. Ms. Tomlinson initially focused on the development of the proprietary database, the tutored taxonomy and validation. Currently, she leads on ensuring the continuing clinical quality of the system and ongoing product development.
Natalie Cronje
Technical Services Director
Natalie Cronje has been with Isabel Healthcare since 2004. Prior to joining Isabel Healthcare she worked as a private practicing Dietitian and lecturer at the University of Pretoria in South Africa. Ms. Cronje initially carried out much of the validation and research work, which has ensured the underlying quality of Isabel. Currently, she works on technical development and with customers on our client support programs.
Dawn Bonsor, RN, B.Eng.
Vice President of Client Services
Ms. Dawn Bonsor joined Isabel in July 2010 as Vice President of Client Services and brings more than 25 years of experience in clinical practice and healthcare informatics. Prior to joining Isabel Ms. Bonsor held leadership positions in implementation planning, customer support and account management with PeriGen and LMS Medical Systems. Ms. Bonsor has a nursing degree from John Abbott College and has a Computer Engineering degree from Concordia University, in Montreal.
Ivan Briery
Co-founder of Voltaire Asset Management, London
Co-Founder of Voltaire Asset Management, London -one of the UK's top performing equity hedge funds during 1998-2002 and formally a partner in Soros Funds.
Terry Hughes
Partner, Hutton Collins
Terry Hughes joined Hutton Collins in 2010. Terry has spent twenty years in leveraged finance and related fields with Continental Illinois, UBS and Goldman Sachs. More recently he headed the principal finance activities for Silver Point LLP in Europe investing in large European acquisition and restructuring situations. Prior to this he was a partner at Goldman Sachs where, over a ten year career, he undertook a variety of roles including heading the leveraged finance and private equity sponsor businesses within Europe. He was closely involved in many of the then defining deals such as financing of Vodafone's bid for Mannesmann and the original funding for the establishment of Orange. He also sat on Goldman Sach's Commitments Committee. Terry is a graduate of Oxford University.
Andrew M. Kanter
Chief Operating Officer, Autonomy Corporation plc, London
Andrew M. Kanter joined Autonomy in August 2000 as Vice President, International Operations and Legal Affairs, and has served as their Chief Operating Officer since 2001. Prior to joining Autonomy, from July 1999 through July 2000, Mr Kanter was an associate attorney with Brobeck Hale and Dorr in London, England, primarily engaged in international mergers and acquisitions and corporate finance. From May 1997 through June 1999, Mr Kanter was an associate attorney in the Business & Technology group of Brobeck, Phleger & Harrison in San Francisco, CA, and prior to that was an associate attorney with Shearman & Sterling, San Francisco, CA. From August 1995 to July 1996 Mr Kanter was Clerk to Hon. Christine Miller of the U.S. Court of Federal Claims, Washington, DC. Mr Kanter holds a J.D. from the University of Southern California Law Center and a B.A. from Johns Hopkins University, and also studied at Kansai University of Foreign Studies, Osaka, Japan.
Juerg Schaeppi
CEO, Bank am Bellevue, Zurich, Switzerland
The Bellevue group is one of the world's leading healthcare investors managing $2 bn assets in BB Biotech and $1 bn in BB Medtech.
Jason Maude
Chief Executive Officer and Co-founder
Jason Maude serves as Chief Executive Officer and Co-founder of Isabel Healthcare Ltd. Prior to co-founding Isabel Healthcare Ltd, Maude spent 12 years working in the finance and investment banking industry in Europe. Throughout his career, Maude served as a top-ranked equity analyst at Kleinwort Benson Securities, Smith Barney and Dillon Read. While at Dillon Read, a prestigious U.S. investment bank, Maude served as partner and managing director of the company's UK office. This prominent position led Maude to AXA Investment Managers where he led equity research and managed $500 billion global investment initiatives.
In 1999, Maude's three-year-old daughter, Isabel fell seriously ill as a result of a misdiagnosis. Isabel's illness and experience inspired Maude to abandon his city career and create Isabel Healthcare.